FrancophonIA/ELRC3.0 huggingface dataset:
English: 1 dose (0.5 ml): HPV Type 6 L1 protein
Croatian: 1 doza (0,5 ml): HPV tip 6 L1 protein
English: Clear liquid with white precipitate.
Croatian: Bistra tekućina s bijelim talogom.
English: • developed an allergic reaction after receiving a dose of Gardasil or Silgard (HPV types 6, 11, 16, and 18) or Gardasil 9.
Croatian: • razvili alergijsku reakciju nakon primljene doze cjepiva Gardasil ili Silgard (tipovi 6, 11, 16 i 18 HPV-a) ili Gardasil 9.
English: Gardasil 9 will not protect against every type of Human Papillomavirus.
Croatian: Gardasil 9 Vas neće zaštititi od svih tipova ljudskog papilomavirusa.
English: Gardasil 9 must not be injected intravascularly, subcutaneously or intradermally.
Croatian: Gardasil 9 se ne smije injicirati intravaskularno, supkutano ili intradermalno.
English: However, in individuals who are already infected with one or more of the vaccine HPV types, Gardasil 9 can still protect against diseases associated with the other HPV types in the vaccine.
Croatian: Međutim, pojedince koji su već zaraženi jednim ili više tipova HPV-a sadržanim u cjepivu, Gardasil 9 i dalje može zaštititi od bolesti prouzročenih preostalim tipovima HPV-a sadržanih u cjepivu.
English: It is also not intended to prevent progression of other established HPV-related lesions.
Croatian: Također nije namijenjeno sprječavanju progresije drugih, već postojećih lezija povezanih s HPV-om.
English: 1 dose of Gardasil 9 suspension for injection contains 0.5 ml.
Croatian: Jedna doza Gardasil 9 suspenzije za injekciju sadrži 0,5 ml.
English: Fainting, sometimes accompanied by shaking or stiffening, has been reported.
Croatian: Prijavljena je nesvjestica, ponekad praćena drhtanjem ili ukočenošću.
English: The full recommended dose of the vaccine should be used.
Croatian: Potrebno je primijeniti punu preporučenu dozu cjepiva.
English: • In packs with needles, two needles of different lengths are provided per syringe.
Croatian: • U pakiranju s iglama, uz svaku štrcaljku priložene su po dvije igle različite duljine.
English: Gardasil 9 protects against the HPV types that cause most cases of these diseases.
Croatian: Gardasil 9 štiti od tipova HPV-a koji uzrokuju većinu tih bolesti.
English: The most common adverse reactions observed with Gardasil 9 were injection-site adverse reactions (84.8% of vaccinees within 5 days following any vaccination visit) and headache (13.2% of the vaccinees within 15 days following any vaccination visit).
Croatian: Najčešće nuspojave opažene s cjepivom Gardasil 9 bile su reakcije na mjestu primjene injekcije (u 84,8% cijepljenih osoba unutar 5 dana nakon bilo kojeg posjeta zbog cijepljenja) i glavobolja (13,2% cijepljenih osoba unutar 15 dana nakon bilo kojeg posjeta zbog cijepljenja).
English: Animal studies do not indicate harmful effects on fertility (see section 5.3).
Croatian: Ispitivanja na životinjama ne ukazuju na štetan učinak na plodnost (vidjeti dio 5.3).
English: Acute disseminated encephalomyelitis, Guillain-Barré syndrome, syncope sometimes accompanied by tonic-clonic movements
Croatian: Poremećaji živčanog sustava nepoznato akutni diseminirani encefalomijelitis, Guillain-Barréov sindrom, sinkopa ponekad praćena toničko-kloničkim kretnjama
English: GMTs were higher in girls and boys than in women aged 16 to 26 years, and higher in boys than in girls and women.
Croatian: GMT-ovi su bili viši u djevojčica i dječaka nego u žena u dobi od 16 do 26 godina i viši u dječaka nego u djevojčica i žena.
English: Gardasil 9 administered to female rats had no effects on development, behaviour, reproductive performance or fertility of the offspring.
Croatian: Gardasil 9 primijenjen u ženki štakora nije imao učinke na razvoj, ponašanje, reproduktivne pokazatelje ili plodnost mladunčadi.
English: If you forget one dose of Gardasil 9
Croatian: Ako ste zaboravili primiti jednu dozu cjepiva Gardasil 9
English: Safety was evaluated using vaccination report card (VRC)-aided surveillance for 14 days after each injection of Gardasil 9.
Croatian: Sigurnost je procijenjena pomoću kartice za izvještavanje o cijepljenju kroz 14 dana nakon svake injekcije cjepiva Gardasil 9.
English: Symptoms may include difficulty breathing, wheezing, hives and/or rash.
Croatian: Simptomi mogu uključivati otežano disanje, piskanje pri disanju, koprivnjaču i/ili osip.
English: In long-term follow-up extension of clinical studies Protocols 001 and 002, persistence of antibody responses was observed:
Croatian: U dugotrajnom nastavku ispitivanja s ciljem praćenja, Protokol 001 i 002, opažena je trajnost odgovora protutijela:
English: Immune responses to Gardasil 9 using a 2-dose schedule in individuals 9 through 14 years of age
Croatian: Imunološki odgovor na Gardasil 9 prema rasporedu za 2 doze u pojedinaca u dobi od 9 do 14 godina
English: Immunogenicity was measured by (1) the percentage of individuals who were seropositive for antibodies against the relevant vaccine HPV type, and (2) the Geometric Mean Titre (GMT).
Croatian: Imunogenost je mjerena (1) postotkom osoba koje su imale seropozitivni nalaz za protutijela na relevantne tipove HPV-a sadržane u cjepivu i (2) geometrijskim srednjim titrom.
English: The second dose should be administered between 5 and 13 months after the first dose.
Croatian: Drugu dozu treba primjeniti između 5 i 13 mjeseci nakon prve doze.
English: What other important information should you or your child know about Gardasil 9
Croatian: Koje još važne informacije Vi ili Vaše dijete morate znati o cjepivu Gardasil 9
English: A total of 15,776 individuals (10,495 subjects aged 16 to 26 years and 5,281 adolescents aged 9 to 15 years at enrolment) received Gardasil 9.
Croatian: Ukupno je 15 776 osoba (10 495 ispitanika u dobi od 16 do 26 godina i 5281 adolescent u dobi od 9 do 15 godina u trenutku uključenja) primilo Gardasil 9.
English: Gardasil 9 can be administered according to a 3-dose (0, 2, 6 months) schedule.
Croatian: Gardasil 9 se može primijeniti prema rasporedu za 3 doze (0, 2, 6 mjeseci).
English: Gardasil 9 may not have an optimal effect if used with medicines that suppress the immune system.
Croatian: Djelovanje cjepiva Gardasil 9 možda neće biti optimalno ako se daje s lijekovima koji potiskuju imunološki sustav.
English: However, the presence of a minor infection, such as a mild upper respiratory tract infection or lowgrade fever, is not a contraindication for immunisation.
Croatian: Međutim, prisutnost manje infekcije, kao što je blaga infekcija gornjeg dijela dišnog sustava ili subfebrilna tjelesna temperatura, nisu kontraindikacije za imunizaciju.
English: Gardasil 9 cannot cause HPV-related diseases.
Croatian: Gardasil 9 ne može prouzročiti bolesti koje uzrokuje HPV.
English: Gardasil 9 contains sodium chloride
Croatian: Gardasil 9 sadrži natrijev klorid.
English: There are no safety, immunogenicity or efficacy data to support interchangeability of Gardasil 9 with bivalent or quadrivalent HPV vaccines.
Croatian: Nema podataka o sigurnosti, imunogenosti ili djelotvornosti koji bi govorili u prilog zamjenjivosti cjepiva Gardasil 9 bivalentnim ili kvadrivalentnim cjepivima protiv HPV-a.
English: In a clinical trial that included 640 individuals aged 27 to 45 years and 570 individuals aged 16 to 26 years who received Gardasil 9, the safety profile of Gardasil 9 was comparable between the two age groups.
Croatian: U kliničkom ispitivanju koje je uključilo 640 osoba u dobi od 27 do 45 godina i 570 osoba u dobi od 16 do 26 godina koje su primile Gardasil 9, sigurnosni profil cjepiva Gardasil 9 bio je usporediv između dvije dobne skupine.
English: In the long-term extension registry study for 16-23 year old women (n = 2,084), no cases of high grade CIN were observed up to approximately 12 years.
Croatian: U dugotrajnom nastavku ispitivanja na temelju registra u žena u dobi od 16-23 godine (N=2084), nije opažen niti jedan slučaj CIN-a visokog stupnja u razdoblju do približno 12 godina.
English: The safety profile was similar to non-HIV infected subjects in other studies.
Croatian: Sigurnosni profil bio je sličan onome zabilježenom u drugim ispitivanjima u osoba koje nisu bile zaražene HIV-om.
English: A study documenting safety and immunogenicity of qHPV vaccine has been performed in 126 HIV infected subjects aged 7 to12 years with baseline CD4% ≥15 and at least 3 months of highly active antiretroviral therapy (HAART) for subjects with a CD4% <25 (of which 96 received qHPV vaccine).
Croatian: Ispitivanje u kojem se dokumentirala sigurnost i imunogenost cjepiva qHPV provedeno je u 126 ispitanika u dobi od 7 do 12 godina zaraženih virusom HIV-a s početnim CD4% ≥15 i najmanje 3 mjeseca visokoaktivne antiretrovirusne terapije (HAART) u ispitanika s CD4% <25 (od kojih je 96 primilo cjepivo qHPV).
English: Gardasil 9 has no or negligible influence on the ability to drive or use machines.
Croatian: Gardasil 9 ne utječe ili zanemarivo utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: The GMTs were somewhat lower than reported in non-HIV infected subjects of the same age in other studies.
Croatian: Geometrijski srednji titri bili su nešto niži od onih prijavljenih u drugim ispitivanjima u ispitanika iste dobi koji nisu bili zaraženi HIV-om.
English: Store in a refrigerator (2ºC - 8ºC).
Croatian: Čuvati u hladnjaku (2ºC-8°C).
English: 60 µg HPV Type 31, 33, 45, 52 and 58 L1 protein 20 µg adsorbed on amorphous aluminium hydroxyphosphate sulfate (0.5 mg Al).
Croatian: 60 μg HPV tip 31, 33, 45, 52 i 58 L1 protein 20 μg adsorbiran na amorfni aluminijev hidroksifosfat sulfat (0,5 mg Al).
English: The CD4% or plasma HIV RNA was not affected by vaccination.
Croatian: Cijepljenje nije utjecalo na CD4% ili RNK HIV-a u plazmi.
English: • for at least 5 years in women who were aged 16 to 26 years at time of vaccination with Gardasil 9, depending on HPV type, 78 to100 % of subjects were seropositive; however, efficacy was maintained in all subjects regardless of seropositivity status for any vaccine HPV type through the end of the study (up to 67 months postdose 3, median follow-up duration of 43 months postdose 3),
Croatian: • tijekom najmanje 5 godina u žena koje su u vrijeme cijepljenja cjepivom Gardasil 9 bile u dobi od 16 do 26 godina; ovisno o tipu HPV-a, 78 do 100% ispitanica bilo je seropozitivno, međutim, djelotvornost je bila održana u svih ispitanica bez obzira na seropozitivnost na bilo koji od tipova HPV-a sadržanih u cjepivu sve do završetka ispitivanja (do 67 mjeseci nakon 3. doze; medijan trajanja praćenja od 43 mjeseca nakon 3. doze),
English: This is based on the results from a clinical trial in which a combined dTap-IPV vaccine was administered concomitantly with the first dose of Gardasil 9 (see section 4.8).
Croatian: Nalaz se temelji na rezultatima kliničkog ispitivanja u kojem se kombinirano cjepivo dTap-IPV primijenilo istodobno s prvom dozom cjepiva Gardasil 9 (vidjeti dio 4.8).
English: Use of hormonal contraceptives did not appear to affect the type-specific immune responses to Gardasil 9.
Croatian: Čini se da primjena hormonskih kontraceptiva nije utjecala na specifični imunološki odgovor na tipove virusa u cjepivu Gardasil 9.
English: Immune responses, measured by GMT, for Gardasil 9 were non-inferior to immune responses for Gardasil (Table 3).
Croatian: Imunološki odgovori, mjereni geometrijskim srednjim titrom, na Gardasil 9 bili su neinferiorni imunološkom odgovoru na Gardasil (Tablica 3).
English: The VLPs cannot infect cells, reproduce or cause disease.
Croatian: Čestice nalik virusu ne mogu inficirati stanice niti se reproducirati ili izazvati bolest.
English: Therefore, vaccinees should be observed for approximately 15 minutes after vaccination.
Croatian: Stoga je cijepljenu osobu potrebno pažljivo nadgledati otprilike 15 minuta nakon primjene cjepiva.
English: • Premalignant lesions and cancers affecting the cervix, vulva, vagina and anus caused by vaccine
Croatian: • premalignih lezija i raka koji zahvaćaju cerviks, vulvu, vaginu i anus, uzrokovanih tipovima
English: For subjects receiving Gardasil 9 after receiving 3 doses of qHPV vaccine, there was an interval of at least 12 months between completion of vaccination with qHPV vaccine and the start of vaccination with Gardasil 9 with a 3-dose regimen (the time interval ranged from approximately 12 to 36 months).
Croatian: Za ispitanike koji su primili Gardasil 9 nakon primanja 3 doze cjepiva qHPV postojao je vremenski razmak od najmanje 12 mjeseci između završetka cijepljenja cjepivom qHPV i početka cijepljenja cjepivom Gardasil 9 prema režimu sa 3 doze (vremenski razmak bio je u rasponu od približno 12 do 36 mjeseci).
English: cLIA= Competitive Luminex Immunoassay.
Croatian: GMT=geometrijski srednji titar. cLIA=kompetitivni Luminex imunološki test.
English: Any unused vaccine or waste material should be disposed of in accordance with local requirements.
Croatian: Neiskorišteno cjepivo ili otpadni materijal potrebno je zbrinuti sukladno nacionalnim propisima.
English: Gardasil 9 is a vaccine for children and adolescents from 9 years of age and adults.
Croatian: Gardasil 9 je cjepivo za djecu i adolescente starije od 9 godina i odrasle.
English: If you or your child receive a first dose of Gardasil 9, you have to complete the full vaccination course with Gardasil 9.
Croatian: Ako Vi ili Vaše dijete primite prvu dozu cjepiva Gardasil 9, morate dovršiti cijelu seriju cijepljenja cjepivom Gardasil 9.
English: These results support the efficacy of Gardasil 9 in the male population.
Croatian: Ovi rezultati podupiru djelotvornost cjepiva Gardasil 9 u muške populacije.
English: A subset of subjects is being followed up for 10 to 14 years after Gardasil 9 vaccination for safety, immunogenicity, and effectiveness against clinical diseases related to the HPV types in the vaccine.
Croatian: Podskupina ispitanika cijepljenih cjepivom Gardasil 9 prati se tijekom 10 do 14 godina radi ocjene sigurnosti, imunogenosti i učinkovitosti protiv kliničkih bolesti povezanih s tipovima HPV-a sadržanima u cjepivu.
English: The efficacy of L1 VLP vaccines is thought to be mediated by the development of a humoral immune response.
Croatian: Smatra se da je djelotvornost L1 čestica nalik virusu sadržanih u cjepivu posredovana razvojem humoralnog imunološkog odgovora.
English: Protocols 005 and 007 evaluated Gardasil 9 concomitantly administered with vaccines recommended routinely in girls and boys aged 11 to 15 years (N=2,295).
Croatian: Protokolima 005 i 007 ocijenio se Gardasil 9 primijenjen istovremeno s cjepivima koja se rutinski preporučuju za djevojčice i dječake u dobi od 11 do 15 godina (N=2295).
English: Gardasil 9 is intended for adolescents and adults from 9 years of age onwards.
Croatian: Gardasil 9 je namijenjen adolescentima i odraslima od 9 godina starosti nadalje.
English: Subjects were followed up to 67 months postdose 3 with a median duration of 43 months postdose 3.
Croatian: Ispitanici su bili praćeni do 67 mjeseci nakon 3. doze uz medijan trajanja od 43 mjeseca nakon 3. doze.
English: See sections 4.4 and 5.1 for important information on the data that support these indications.
Croatian: Za važne informacije o podacima na kojima se temelje ove indikacije, vidjeti dijelove 4.4 i 5.1.
English: In a post hoc analysis for HPV 6 and 11, the GMT ratios were 0.76 and 0.81 respectively.
Croatian: U post hoc analizi za HPV tipove 6 i 11, omjeri GMT-ova bili su 0,76 za tip 6 i 0,81 za tip 11.
English: Pre-filled syringe, pack of 10
Croatian: Napunjena štrcaljka, pakiranje od 10
English: The preferred site is the deltoid area of the upper arm or in the higher anterolateral area of the thigh.
Croatian: Poželjno mjesto je deltoidno područje nadlaktice ili gornje anterolateralno područje bedra.
English: If you or your child already received an HPV vaccine, ask your doctor if Gardasil 9 is right for you.
Croatian: Ako ste Vi ili Vaše dijete već primili cjepivo protiv HPV-a, upitajte liječnika je li Gardasil 9 pravo cjepivo za vas.
English: Adverse reactions considered as being at least possibly related to vaccination have been categorised by frequency.
Croatian: Nuspojave za koje se smatralo da postoji barem mogućnost da su povezane s cijepljenjem svrstane su u kategorije prema učestalosti.
English: Immune response to Gardasil 9 at Month 7
Croatian: Imunološki odgovor na Gardasil 9 u 7. mjesecu
English: A total of 92 women were breast-feeding during the vaccination period of the clinical studies of Gardasil 9 in women aged 16 to 26 years.
Croatian: Ukupno 92 žene dojile su u razdoblju cijepljenja tijekom kliničkih ispitivanja cjepiva Gardasil 9 u žena u dobi od 16 do 26 godina.
English: 2778 South East Side Highway
Croatian: 2778 South East Side Highway Elkton, Virginia, 22827,
English: Individuals with hypersensitivity after previous administration of Gardasil 9 or Gardasil/Silgard should not receive Gardasil 9.
Croatian: Osobe s preosjetljivošću nakon prethodne primjene cjepiva Gardasil 9 ili cjepiva Gardasil/Silgard ne smiju primiti Gardasil 9.
English: Persistent infection detected in samples from three or more consecutive visits 6 months (±1 month visit windows) apart.
Croatian: Perzistentna infekcija otkrivena u uzorcima prilikom tri ili više uzastopnih posjeta u razmaku od 6 mjeseci (±1 mjesec).
English: Gardasil 9 does not have any effect in individuals who already have a persistent infection or disease associated with any of the HPV types in the vaccine.
Croatian: Gardasil 9 nema nikakvog učinka u osoba koje već imaju trajnu infekciju ili bolest izazvanu nekim tipom HPV-a koji se nalazi u cjepivu.
English: Evidence of an anamnestic response was seen in vaccinated women who were seropositive to relevant HPV type(s) prior to vaccination.
Croatian: Dokazi anamnestičkog odgovora opaženi su u cijepljenih žena koje su bile seropozitivne na jedan ili više relevantnih tipova HPV-a prije cijepljenja.
English: Specific studies of Gardasil 9 in pregnant women were not conducted.
Croatian: Nisu provedena posebna ispitivanja cjepiva Gardasil 9 u trudnica.
English: The vaccine is therefore not indicated for treatment of cervical, vulvar, vaginal and anal cancer, high-grade cervical, vulvar, vaginal and anal dysplastic lesions or genital warts.
Croatian: Stoga ovo cjepivo nije indicirano za liječenje raka cerviksa, vulve, vagine ili anusa, displastičkih lezija visokog stupnja na cerviksu, vulvi, vagini i anusu ili genitalnih bradavica.
English: Name and address of the manufacturer(s) of the biological active substance(s) Merck Sharp & Dohme Corp.
Croatian: Naziv(i) i adresa(e) proizvođača biološke(ih) djelatne(ih) tvari Merck Sharp & Dohme Corp.
English: No human data on the effect of Gardasil 9 on fertility are available.
Croatian: Nema dostupnih podataka o učinku cjepiva Gardasil 9 na plodnost u ljudi.
English: - If you have any further questions, please ask your doctor, pharmacist or nurse.
Croatian: Ako imate dodatnih pitanja, obratite se liječniku, ljekarniku ili medicinskoj sestri.
English: Gardasil 9/ qHPV Vaccine
Croatian: Gardasil 9/ cjepivo qHPV
English: 0.5 ml suspension in a pre-filled syringe (glass) with plunger stopper (siliconised FluroTec-laminated bromobutyl elastomer) and a tip cap (synthetic isoprene-bromobutyl blend) in pack sizes of 1 or 10 with needles or in a pack size of 10 without needles.
Croatian: 0,5 ml suspenzije u napunjenoj štrcaljki (staklo) s čepom na klipu (silikonizirani bromobutilni elastomer obložen FluroTecom ) i zatvaračem na vrhu (mješavima sintetičkog izopren-bromobutila) u pakiranju od 1 ili 10 napunjenih štrcaljki s iglama ili u pakiranju od 10 napunjenih štrcaljki bez igala.
English: As expected for women 27 to 45 years of age (Protocol 004), the observed GMTs were lower than those seen in women aged 16 to 26 years.
Croatian: Kao što je i očekivano, opaženi GMT-ovi u žena u dobi od 27 do 45 godina (Protokol 004) bili su niži nego oni u žena u dobi od 16 do 26 godina.
English: The vaccine is not used to treat HPV related diseases.
Croatian: To se cjepivo ne koristi u liječenju bolesti koje izaziva HPV.
English: p-value <0.001.
Croatian: mMU=mili-Merck jedinice. p-vrijednost <0,001.
English: Persistent infection detected in samples from two or more consecutive visits 6 months (±1 month visit windows) apart.
Croatian: Perzistentna infekcija otkrivena u uzorcima prilikom dva ili više uzastopnih posjeta u razmaku od 6 mjeseci (±1 mjesec).
English: Use with other vaccines
Croatian: Primjena s ostalim cjepivima
English: Individuals 9 to and including 14 years of age at time of first injection Gardasil 9 can be administered according to a 2-dose (0, 6 - 12 months) schedule (see section 5.1).
Croatian: Pojedinci u dobi od 9 do uključujući i 14 godina u vrijeme prve injekcije Gardasil 9 se može primijeniti prema rasporedu za 2 doze (0, 6-12 mjeseci) (vidjeti dio 5.1).
English: Table 2: Adverse reactions reported from Post-marketing experience with qHPV vaccine System organ class
Croatian: Tablica 2: Nuspojave prijavljene nakon stavljanja u promet cjepiva qHPV Klasifikacija organskih sustava Učestalost
English: What Gardasil 9 contains
Croatian: Što Gardasil 9 sadrži
English: The need for a booster dose has not been established.
Croatian: Nije ustanovljeno je li potrebna doza za docjepljivanje.
English: Very common (may affect more than 1 in 10 people): side effects found at the injection site (pain, swelling, and redness) and headache.
Croatian: Vrlo često (mogu se javiti u više od 1 na 10 osoba): nuspojave zamijećene na mjestu injekcije (bol, oticanje i crvenilo) i glavobolja.
English: As with any vaccine, Gardasil 9 may not fully protect all of those who get the vaccine.
Croatian: Kao i ostala cjepiva, Gardasil 9 neće potpuno zaštititi sve osobe koje su primile cjepivo.
English: In clinical studies, 60.2% of women aged 16 to 26 years who received Gardasil 9 used hormonal contraceptives during the vaccination period of the clinical studies.
Croatian: U kliničkim ispitivanjima, 60,2% žena u dobi od 16 do 26 godina koje su primile Gardasil 9 uzimalo je hormonske kontraceptive tijekom razdoblja cijepljenja u kliničkim ispitivanjima.
English: Safety and immunogenicity in individuals who have received immunoglobulin or blood-derived products during the 3 months prior to vaccination have not been studied in clinical trials.
Croatian: U kliničkim ispitivanjima nisu ispitane sigurnost i imunogenost u osoba koje su primile imunoglobulin ili pripravke dobivene iz krvi u razdoblju od 3 mjeseca prije cijepljenja.
English: If you have any further questions on the use of this vaccine, ask your doctor or pharmacist.
Croatian: U slučaju bilo kakvih pitanja u vezi s primjenom ovog cjepiva, obratite se liječniku ili ljekarniku.
English: If you are from 9 to and including 14 years of age at time of first injection Gardasil 9 can be administered according to a 2-dose schedule:
Croatian: Ako ste u dobi od 9 do uključujući i 14 godina u vrijeme prve injekcije Gardasil 9 može se primijeniti prema rasporedu za 2 doze:
English: Hypersensitivity reactions including anaphylactic/anaphylactoid reactions, bronchospasm and urticaria
Croatian: Poremećaji imunološkog sustava nepoznato reakcije preosjetljivosti uključujući anafilaktičke/anafilaktoidne reakcije, bronhospazam i urtikariju
English: During the clinical development of Gardasil 9; 2,586 women (1,347 in the Gardasil 9 group vs. 1,239 in the qHPV vaccine group) reported at least one pregnancy.
Croatian: Tijekom kliničkog razvoja cjepiva Gardasil 9, 2586 žena (1347 u skupini koja je primila Gardasil 9 naspram 1239 žena u skupini koja je primila cjepivo qHPV) prijavilo je najmanje jednu trudnoću.
English: These assays measured antibodies against neutralising epitopes for each HPV type.
Croatian: Ti su testovi mjerili protutijela na neutralizirajuće epitope kod svakog od tipova HPV-a u cjepivu.
English: One month following the last dose of the assigned regimen, between 97.9% and 100% of subjects across all groups became seropositive for antibodies against the 9 vaccine HPV types.
Croatian: Mjesec dana nakon posljednje doze dodijeljenog režima cijepljenja, između 97,9% i 100% ispitanika u svim skupinama postalo je seropozitivno na protutijela na 9 tipova HPV-a u cjepivu.
English: Gardasil 9 has been studied in males 9 to 26 years of age and females 9 to 45 years of age.
Croatian: Gardasil 9 je ispitan u muškaraca u dobi od 9 do 26 godina i žena u dobi od 9 do 45 godina.